Cargando…
The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease
Chronic graft-versus-host disease (cGVHD) is a leading cause of late morbidity and mortality following allogeneic stem cell transplantation. Current therapies, including corticosteroids and calcineurin inhibitors, are only effective in roughly 50% of cases; therefore, new treatment strategies are un...
Autores principales: | Rhoades, Ruben, Gaballa, Sameh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5744085/ https://www.ncbi.nlm.nih.gov/pubmed/29039818 http://dx.doi.org/10.3390/biomedicines5040061 |
Ejemplares similares
-
The role of B cells in acute graft-versus-host disease
por: Cho, Byung-Sik, et al.
Publicado: (2011) -
Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
por: Kim, Sena, et al.
Publicado: (2020) -
Evidence for B Cell Exhaustion in Chronic Graft-versus-Host Disease
por: Khoder, Ahmad, et al.
Publicado: (2018) -
Mast Cell Involvement in Fibrosis in Chronic Graft-Versus-Host Disease
por: Strattan, Ethan, et al.
Publicado: (2021) -
Role of αβ T Cell Depletion in Prevention of Graft versus Host Disease
por: Abdelhakim, Haitham, et al.
Publicado: (2017)